Our ion channel screening and cardiac safety services
Validated ion channel screening assays against an extensive panel of ion channel cell lines using a variety of high quality ion channel screening platforms with a range of throughput capabilities.
Cardiac safety screening services against a premium panel of validated Comprehensive in Vitro Proarrhythmia Assay (CiPA) compliant human cardiac ion channel screening assays, including GLP hERG.
Neuroscience-related ion channel screening assays and platforms for native tissue and species selectivity testing, as well as more general neurotoxicology screening of hits and lead candidates.
A number of phenotypic assays to aid the translation of in vitro cardiac safety and neuroscience data to the preclinical stage.
We have extensive experience supporting customers integrated ion channel research programmes, and a strong track record delivering high quality assays, screening data to defined timelines and clinical candidates.